发明名称 Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
摘要 The invention discloses the discovery that a pharmaceutical composition containing complex carbohydrates with or without natural or synthetic essential oils can work effectively as a topical, oral or mucosal pharmaceutical composition. Such pharmaceutical compositions reduce inflammation, assist in wound healing, protect against bruising, relieve itching, relieve pain and swelling and treat topical bacterial infections such as acne and decubitus ulcers and prevent and treat numerous other conditions and diseases. Such pharmaceutical compositions can be administered to mammals including humans. Also included in this invention are methods to deliver topically applied macromolecules into the tissue of mammals and methods of blocking the adhesion, metastatic and coronary cascades.
申请公布号 US9220290(B2) 申请公布日期 2015.12.29
申请号 US201313933906 申请日期 2013.07.02
申请人 DERMAL RESEARCH LABORATORIES, INC. 发明人 Brown Harold G.;Cooper Carol A.;Hennessy Kristina J.;Brown Karen K.
分类号 A61K31/728;A23L1/30;A61K9/00;A61K31/715;A61K31/726;A61K31/727;A61K31/736;A61K31/737;A61K47/44;A23K1/16 主分类号 A61K31/728
代理机构 Birch, Stewart, Kolasch & Birch, LLP 代理人 Birch, Stewart, Kolasch & Birch, LLP
主权项 1. An orally ingestable or mucosally absorbed low purity hyaluronic acid or salt thereof composition, which comprises, an effective amount of said at least one orally ingestable or mucosally absorbed low purity hyaluronic acid or salt thereof and an effective amount of a preservative, wherein said low purity hyaluronic acid or salt thereof functions at a site remote from oral ingestion or mucosal absorption comprising at least one hyaluronic acid fraction having a molecular weight in the range of greater than 1,000,000 daltons, as measured using a protein standard/intrinsic viscosity, with the proviso that said composition does not contain an essential oil as an active ingredient, wherein the low purity hyaluronic acid or salt thereof contains up to 5% by weight contaminants that would result in microbial growth if the low purity hyaluronic acid or salt thereof is placed into water which does not contain a preservative and is not a pharmaceutical grade; and wherein the up to 5% by weight contaminants comprise a pyrogenic component such that said composition causes a pyrogenic effect if injected.
地址 Parkville MO US